• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病的全球负担:改善的挑战。

The global burden of cardiovascular diseases: a challenge to improve.

机构信息

Noncommunicable Diseases, World Health Organization, Geneva, Switzerland,

出版信息

Curr Cardiol Rep. 2014 May;16(5):486. doi: 10.1007/s11886-014-0486-3.

DOI:10.1007/s11886-014-0486-3
PMID:24718672
Abstract

There are many challenges that need to be overcome to address the global cardiovascular disease epidemic. They include (1) lack of multisectoral action to support reduction of behavioral risk factors and their determinants, (2) weak public health and health care system capacity for forging an accelerated national response, and (3) inefficient use of limited resources. To make progress, countries need to develop and implement multisectoral national action plans guided by the global action plan for prevention and control of noncommunicable diseases, strengthen surveillance and monitoring systems, and set national targets consistent with global voluntary targets, which are to be attained by 2025. In addition, a set of cost-effective preventive and curative interventions need to be prioritized. Further, resources need to be generated and capacity developed to ensure sustainable country-wide implementation of the prioritized interventions. According to WHO estimates, the implementation of a core set of very cost-effective interventions for prevention and control of cardiovascular disease requires about 4 % of current health spending in lower income countries, 2 % in lower middle income countries, and less than 1 % in upper middle income and high income countries.

摘要

要应对全球心血管疾病流行,需要克服诸多挑战。这些挑战包括:(1)缺乏多部门行动来支持减少行为风险因素及其决定因素;(2)公共卫生和医疗保健系统能力薄弱,无法快速应对;(3)有限资源利用效率低下。为取得进展,各国需要在预防和控制非传染性疾病全球行动计划的指导下制定和实施多部门国家行动计划,加强监测系统,并制定与全球自愿目标一致的国家目标,这些目标将在 2025 年实现。此外,需要优先考虑一系列具有成本效益的预防和治疗干预措施。此外,需要筹集资源并发展能力,以确保在全国范围内可持续地实施优先干预措施。根据世卫组织的估计,实施预防和控制心血管疾病的一组非常具有成本效益的核心干预措施,大约需要低收入国家当前卫生支出的 4%、中低收入国家的 2%以及中高收入和高收入国家的不到 1%。

相似文献

1
The global burden of cardiovascular diseases: a challenge to improve.心血管疾病的全球负担:改善的挑战。
Curr Cardiol Rep. 2014 May;16(5):486. doi: 10.1007/s11886-014-0486-3.
2
Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.在非洲,预防、治疗和控制心血管疾病和糖尿病的干预措施的成本、效益和效果。
Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):314-21. doi: 10.1016/j.pcad.2013.09.001.
3
[Health policy interventions: the pathway to public health].[卫生政策干预措施:通往公共卫生之路]
Laeknabladid. 2013 Mar;99(3):129-34. doi: 10.17992/lbl.2013.03.487.
4
Tuberculosis结核病
5
Non-communicable diseases in the Arab world.阿拉伯世界的非传染性疾病。
Lancet. 2014 Jan 25;383(9914):356-67. doi: 10.1016/S0140-6736(13)62383-1. Epub 2014 Jan 20.
6
The unfunded priorities: an evaluation of priority setting for noncommunicable disease control in Uganda.未得到资金支持的优先事项:乌干达非传染性疾病控制优先事项设定评估。
Global Health. 2018 Feb 20;14(1):22. doi: 10.1186/s12992-018-0324-2.
7
Noncommunicable Disease (NCD) strategic plans in low- and lower-middle income Sub-Saharan Africa: framing and policy response.撒哈拉以南非洲低收入和中低收入国家的非传染性疾病(NCD)战略计划:框架和政策应对。
Glob Health Action. 2020 Dec 31;13(1):1805165. doi: 10.1080/16549716.2020.1805165.
8
An analytical perspective of Global health initiatives in Tanzania and Zambia.坦桑尼亚和赞比亚全球卫生倡议的分析视角
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4(Suppl 4):223. doi: 10.1186/s12913-016-1449-8.
9
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
10
Challenges and opportunities for cardiovascular disease prevention.心血管疾病预防的挑战与机遇。
Am J Med. 2011 Feb;124(2):95-102. doi: 10.1016/j.amjmed.2010.08.015.

引用本文的文献

1
Towards integrated cardiovascular and mental health management in primary health care in Indonesia: a policy outlook.印度尼西亚初级卫生保健中综合心血管与心理健康管理的政策展望
Lancet Reg Health Southeast Asia. 2025 May 27;37:100605. doi: 10.1016/j.lansea.2025.100605. eCollection 2025 Jun.
2
Degradation of the α-Carboxyl Terminus 11 Peptide: and Impacts of Time, Temperature, Inhibitors, and Gender in Rat.α-羧基末端11肽的降解:以及时间、温度、抑制剂和性别的影响(在大鼠中)
ACS Pharmacol Transl Sci. 2024 Apr 22;7(5):1624-1636. doi: 10.1021/acsptsci.4c00120. eCollection 2024 May 10.
3
Independent and joint associations of cardiorespiratory fitness and lower-limb muscle strength with cardiometabolic risk in older adults.

本文引用的文献

1
Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.在非洲,预防、治疗和控制心血管疾病和糖尿病的干预措施的成本、效益和效果。
Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):314-21. doi: 10.1016/j.pcad.2013.09.001.
2
Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions.资源匮乏地区初级保健机构在实施基本非传染性疾病干预措施方面的能力差距。
Int J Hypertens. 2012;2012:584041. doi: 10.1155/2012/584041. Epub 2012 Nov 29.
3
Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
独立且联合的心肺功能适应性和下肢肌肉力量与老年人心脏代谢风险的关联。
PLoS One. 2023 Oct 23;18(10):e0292957. doi: 10.1371/journal.pone.0292957. eCollection 2023.
4
Closing gaps in medication taking for secondary prevention of coronary heart disease patients among US adults.缩小美国成年人中冠心病患者二级预防用药方面的差距。
Heliyon. 2022 Nov 11;8(11):e11530. doi: 10.1016/j.heliyon.2022.e11530. eCollection 2022 Nov.
5
A review on the potential of underutilized Blackjack naturally occurring in sub-Saharan Africa.关于撒哈拉以南非洲自然生长的未充分利用的黑杰克潜力的综述。
Heliyon. 2022 May 29;8(6):e09586. doi: 10.1016/j.heliyon.2022.e09586. eCollection 2022 Jun.
6
Joint modeling of blood pressure measurement and survival time of hypertension patients.高血压患者血压测量值与生存时间的联合建模。
Sci Rep. 2021 Aug 3;11(1):15731. doi: 10.1038/s41598-021-94905-y.
7
Impact of Musculoskeletal Limitations on Cardiac Rehabilitation Participation.肌肉骨骼限制对心脏康复参与度的影响。
Front Cardiovasc Med. 2021 Jun 28;8:688483. doi: 10.3389/fcvm.2021.688483. eCollection 2021.
8
Vaccines Targeting PSCK9 for the Treatment of Hyperlipidemia.靶向前蛋白转化酶枯草溶菌素9的降脂疫苗
Cardiol Ther. 2020 Dec;9(2):323-332. doi: 10.1007/s40119-020-00191-6. Epub 2020 Jul 31.
9
Strengthening complex systems for chronic disease prevention: a systematic review.强化慢性病预防的复杂系统:系统评价。
BMC Public Health. 2019 Jun 11;19(1):729. doi: 10.1186/s12889-019-7021-9.
10
Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients.循环中前蛋白转化酶枯草溶菌素9(PCSK9)浓度升高可预测低风险肥胖和非肥胖患者的亚临床动脉粥样硬化改变。
Cardiol Ther. 2017 Dec;6(2):281-289. doi: 10.1007/s40119-017-0092-8. Epub 2017 Jun 16.
撒哈拉以南非洲和东南亚地区防治心血管疾病、糖尿病和烟草使用的策略的成本效益:数学模型研究。
BMJ. 2012 Mar 2;344:e607. doi: 10.1136/bmj.e607.
4
Salt reduction initiatives around the world.全球减盐行动。
J Hypertens. 2011 Jun;29(6):1043-50. doi: 10.1097/HJH.0b013e328345ed83.
5
Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles.塞舌尔群岛单危险因素与总体风险管理预防心血管事件的潜在影响。
Bull World Health Organ. 2011 Apr 1;89(4):286-95. doi: 10.2471/BLT.10.082370. Epub 2011 Feb 17.
6
Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness.解决不健康饮食、缺乏身体活动和肥胖问题:健康影响和成本效益。
Lancet. 2010 Nov 20;376(9754):1775-84. doi: 10.1016/S0140-6736(10)61514-0. Epub 2010 Nov 10.
7
Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial.心血管风险管理及其对资源匮乏环境下初级保健中高血压控制的影响:一项集群随机试验。
Bull World Health Organ. 2010 Jun;88(6):412-9. doi: 10.2471/BLT.08.062364. Epub 2009 Dec 8.
8
Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol.减少酒精危害的政策与项目的有效性及成本效益
Lancet. 2009 Jun 27;373(9682):2234-46. doi: 10.1016/S0140-6736(09)60744-3.